555 related articles for article (PubMed ID: 36189286)
1. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
Front Immunol; 2022; 13():952987. PubMed ID: 36189286
[TBL] [Abstract][Full Text] [Related]
2. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
3. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
[TBL] [Abstract][Full Text] [Related]
4. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
[TBL] [Abstract][Full Text] [Related]
5. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
Retornaz F; Rebaudet S; Stavris C; Jammes Y
J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
[TBL] [Abstract][Full Text] [Related]
6. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Campen CLMCV; Rowe PC; Visser FC
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
[No Abstract] [Full Text] [Related]
7. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
Front Immunol; 2022; 13():949787. PubMed ID: 36341457
[TBL] [Abstract][Full Text] [Related]
8. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
[TBL] [Abstract][Full Text] [Related]
9. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
[TBL] [Abstract][Full Text] [Related]
10. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
Komaroff AL; Lipkin WI
Trends Mol Med; 2021 Sep; 27(9):895-906. PubMed ID: 34175230
[TBL] [Abstract][Full Text] [Related]
11. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
[TBL] [Abstract][Full Text] [Related]
12. Pre-pandemic activity on a myalgic encephalomyelitis/chronic fatigue syndrome support forum is highly associated with later activity on a long COVID support forum for a variety of reasons: A mixed methods study.
Meyerson WU; Hoyle RH
PLoS One; 2023; 18(9):e0291173. PubMed ID: 37682908
[TBL] [Abstract][Full Text] [Related]
13. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
[TBL] [Abstract][Full Text] [Related]
14. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
Wong TL; Weitzer DJ
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925784
[No Abstract] [Full Text] [Related]
15. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID.
Tokumasu K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Yamamoto K; Nakano Y; Hasegawa T; Yamamoto Y; Otsuka Y; Hagiya H; Kataoka H; Ueda K; Otsuka F
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888568
[No Abstract] [Full Text] [Related]
16. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
Nunes JM; Kell DB; Pretorius E
Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
[TBL] [Abstract][Full Text] [Related]
17. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
[TBL] [Abstract][Full Text] [Related]
18. Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue Center.
Steiner S; Fehrer A; Hoheisel F; Schoening S; Aschenbrenner A; Babel N; Bellmann-Strobl J; Finke C; Fluge Ø; Froehlich L; Goebel A; Grande B; Haas JP; Hohberger B; Jason LA; Komaroff AL; Lacerda E; Liebl M; Maier A; Mella O; Nacul L; Paul F; Prusty BK; Puta C; Riemekasten G; Ries W; Rowe PC; Sawitzki B; Shoenfeld Y; Schultze JL; Seifert M; Sepúlveda N; Sotzny F; Stein E; Stingl M; Ufer F; Veauthier C; Westermeier F; Wirth K; Wolfarth B; Zalewski P; Behrends U; Scheibenbogen C
Autoimmun Rev; 2023 Nov; 22(11):103452. PubMed ID: 37742748
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
[TBL] [Abstract][Full Text] [Related]
20. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
Paul BD; Lemle MD; Komaroff AL; Snyder SH
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34400495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
